Targeting the cancer chaperone HSP90
Authors:
- Jennifer R. SmithJSJennifer R. Smith
- Paul WorkmanPWPaul Workman
- 29 February 2008
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Therapeutic Strategies
- Vol. 4 (4) , 219-227
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Drugging the Cancer Chaperone HSP90Annals of the New York Academy of Sciences, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Structure and Mechanism of the Hsp90 Molecular Chaperone MachineryAnnual Review of Biochemistry, 2006
- Radanamycin, a macrocyclic chimera of radicicol and geldanamycinBioorganic & Medicinal Chemistry Letters, 2006
- HSP90 and the chaperoning of cancerNature Reviews Cancer, 2005
- Radester, a Novel Inhibitor of the Hsp90 Protein Folding MachineryOrganic Letters, 2005
- Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperoneCancer Letters, 2004
- Development of Radicicol AnaloguesCurrent Cancer Drug Targets, 2003
- The Hallmarks of CancerCell, 2000
- Preclinical pharmacologic evaluation of geldanamycin as an antitumor agentCancer Chemotherapy and Pharmacology, 1995